A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patients
2006 ◽
Vol 42
(15)
◽
pp. 2530-2538
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 5151-5151
◽
2017 ◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 2600-2600
◽